• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Trending
Screeners
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6886.69
6886.69
6886.69
6900.68
6824.70
+46.18
+ 0.68%
--
DJI
Dow Jones Industrial Average
48057.74
48057.74
48057.74
48197.30
47462.94
+497.46
+ 1.05%
--
IXIC
NASDAQ Composite Index
23654.15
23654.15
23654.15
23704.08
23435.17
+77.67
+ 0.33%
--
USDX
US Dollar Index
98.230
98.310
98.230
98.720
98.220
-0.360
-0.37%
--
EURUSD
Euro / US Dollar
1.17392
1.17401
1.17392
1.17405
1.16821
+0.00444
+ 0.38%
--
GBPUSD
Pound Sterling / US Dollar
1.34199
1.34210
1.34199
1.34206
1.33543
+0.00402
+ 0.30%
--
XAUUSD
Gold / US Dollar
4227.13
4227.47
4227.13
4247.68
4204.22
-1.09
-0.03%
--
WTI
Light Sweet Crude Oil
57.166
57.196
57.166
58.772
57.148
-1.511
-2.58%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

Canadian Dollar Strengthens To A Near Three-Month High At 1.3775 Per USA Dollar

Share

London Metal Exchange Three Month Copper Rises To All-Time High Of $11780 A Ton, Last Up 1.9%

Share

Senegal Energy Ministry: Kosmos Remains Country's Strategic Partner

Share

Senegal Energy Ministry: Country's Oil And Gas Strategy Does Not Imply Nationalization Of Yakaar-Teranga Project

Share

India Prime Minister Modi: India And The USA Will Continue To Work Together For Global Peace, Stability And Prosperity

Share

Indian Prime Minister Modi: Had A Very Warm And Engaging Conversation With President Trump

Share

Roi-Powell Bets Big On Productivity Boost Rescuing Boxed-In Fed: Mcgeever

Share

Oracle 5-Year Cds Surge To 139 Bps, Up Nearly 12 Bps From Last Close, S&P Global Market Intelligence Data Shows

Share

Disney - Openai & Disney Have Affirmed Commitment To Maintaining Robust Controls To Prevent Generation Of Illegal Or Harmful Content

Share

Czech Central Bank Says 6 Out Of 7 Board Members Will Attend December 18 Policy Meeting

Share

Fed Data - USA Effective Federal Funds Rate At 3.89 Percent On 10 December On $98 Billion In Trades Versus 3.89 Percent On $85 Billion On 09 December

Share

BOE Governor Bailey: Continued Qt Needed To End Interest Rate Risk

Share

According To Data From The Federal Reserve Bank Of New York, The Secured Overnight Funding Rate (Sofr) Was 3.90% On The Previous Trading Day (December 10, The Day The Fed Cut Interest Rates And Announced The Rmp Bond Purchase Program), Compared To 3.93% The Day Before

Share

Irish Finance Minister: We Think Article 122 Does Provide Legal Basis To Immobilise Russian Frozen Assets

Share

Brazil's Durigan: We Need To Ensure That Our Monetary Policy And Fiscal Policy Converge

Share

European Banking Federation: Concrete And Determined Steps Must Now Follow To Enhance The Global Competitiveness Of The EU's Financial Sector

Share

Brazil's Durigan: We Are Seeking Balance Between Left-Wing Defense Of Disproportionate Spending And Right-Wing View Of Excessive Fiscal Austerity

Share

Irish Finance Minister: We Will Take Measures To Immobilise Russian Assets For Long Term In Coming Days

Share

European Banking Federation: EU Policymakers Should Not Hesitate To Cut Overlapping EU Goldplating Measures In Their Efforts To Reduce Complexity

Share

European Banking Federation On European Central Bank Capital Rules Proposals: Welcomes European Central Bank Report On Banking Rules Simplification

TIME
ACT
FCST
PREV
U.S. Federal Funds Rate Projections-Longer Run (Q4)

A:--

F: --

P: --

U.S. Federal Funds Rate Projections-1st Year (Q4)

A:--

F: --

P: --

U.S. Target Federal Funds Rate Lower Limit (Overnight Reverse Repo Rate)

A:--

F: --

P: --

U.S. Federal Funds Rate Projections-2nd Year (Q4)

A:--

F: --

P: --

U.S. Budget Balance (Nov)

A:--

F: --

P: --

U.S. Target Federal Funds Rate Upper Limit (Excess Reserves Ratio)

A:--

F: --

P: --

FOMC Statement
FOMC Press Conference
Brazil Selic Interest Rate

A:--

F: --

P: --

U.K. 3-Month RICS House Price Balance (Nov)

A:--

F: --

P: --

Australia Employment (Nov)

A:--

F: --

P: --
Australia Full-time Employment (SA) (Nov)

A:--

F: --

P: --

Australia Unemployment Rate (SA) (Nov)

A:--

F: --

P: --

Australia Labor Force Participation Rate (SA) (Nov)

A:--

F: --

P: --

Turkey Retail Sales YoY (Oct)

A:--

F: --

P: --

South Africa Mining Output YoY (Oct)

A:--

F: --

P: --

South Africa Gold Production YoY (Oct)

A:--

F: --

P: --

Italy Quarterly Unemployment Rate (SA) (Q3)

A:--

F: --

P: --

IEA Oil Market Report
Turkey 1-Week Repo Rate

A:--

F: --

P: --

South Africa Refinitiv/Ipsos Primary Consumer Sentiment Index (PCSI) (Dec)

A:--

F: --

P: --

Turkey Overnight Lending Rate (O/N) (Dec)

A:--

F: --

P: --

Turkey Late Liquidity Window Rate (LON) (Dec)

A:--

F: --

P: --

U.K. Refinitiv/Ipsos Primary Consumer Sentiment Index (PCSI) (Dec)

A:--

F: --

P: --

Brazil Retail Sales MoM (Oct)

A:--

F: --

P: --

U.S. Weekly Continued Jobless Claims (SA)

A:--

F: --

P: --
U.S. Exports (Sept)

A:--

F: --

P: --

U.S. Trade Balance (Sept)

A:--

F: --

P: --
U.S. Weekly Initial Jobless Claims (SA)

A:--

F: --

P: --
Canada Imports (SA) (Sept)

A:--

F: --

P: --
U.S. Initial Jobless Claims 4-Week Avg. (SA)

A:--

F: --

P: --

Canada Trade Balance (SA) (Sept)

A:--

F: --

P: --
Canada Exports (SA) (Sept)

A:--

F: --

P: --
U.S. Wholesale Sales MoM (SA) (Sept)

--

F: --

P: --

U.S. EIA Weekly Natural Gas Stocks Change

--

F: --

P: --

U.S. 30-Year Bond Auction Avg. Yield

--

F: --

P: --

Argentina CPI MoM (Nov)

--

F: --

P: --

Argentina National CPI YoY (Nov)

--

F: --

P: --

Argentina 12-Month CPI (Nov)

--

F: --

P: --

U.S. Weekly Treasuries Held by Foreign Central Banks

--

F: --

P: --

Japan Industrial Output Final MoM (Oct)

--

F: --

P: --

Japan Industrial Output Final YoY (Oct)

--

F: --

P: --

U.K. Services Index MoM (SA) (Oct)

--

F: --

P: --

U.K. Services Index YoY (Oct)

--

F: --

P: --

Germany HICP Final YoY (Nov)

--

F: --

P: --

Germany HICP Final MoM (Nov)

--

F: --

P: --

U.K. Trade Balance Non-EU (SA) (Oct)

--

F: --

P: --

U.K. Trade Balance (Oct)

--

F: --

P: --

U.K. Services Index MoM

--

F: --

P: --

U.K. Construction Output MoM (SA) (Oct)

--

F: --

P: --

U.K. Industrial Output YoY (Oct)

--

F: --

P: --

U.K. Trade Balance (SA) (Oct)

--

F: --

P: --

U.K. Trade Balance EU (SA) (Oct)

--

F: --

P: --

U.K. Manufacturing Output YoY (Oct)

--

F: --

P: --

U.K. GDP MoM (Oct)

--

F: --

P: --

U.K. GDP YoY (SA) (Oct)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Fresenius Medical Care AG : Release of a capital market information

          EQS
          Fresenius Medical Care
          +3.04%

          Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Fresenius Medical Care AG : Release of a capital market information

          08.12.2025 / 15:53 CET/CEST

          Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.

          The issuer is solely responsible for the content of this announcement.

          Fresenius Medical Care AG: Share buyback

           

          Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Share buyback – Interim Report

          In the period from December 1, 2025 to December 5, 2025 (each inclusive), 1,354,000 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

          Shares were bought back as follows:

          DateAcquired shares (number)Weighted average price (in EUR)Transaction volume (in EUR)Trading venue
          1 December 202520,00040.9293818,585.51CEUX
          1 December 2025180,00041.00797,381,427.48XETA
          2 December 202580,00040.74953,259,961.48CEUX
          2 December 2025170,00040.74196,926,118.36XETA
          3 December 202511,00040.4573445,030.18AQEU
          3 December 2025110,00040.46014,450,611.43CEUX
          3 December 20259,00040.4556364,100.82TQEX
          3 December 2025170,00040.46316,878,731.09XETA
          4 December 202517,30640.2356696,317.97AQEU
          4 December 2025100,00040.38004,037,995.08CEUX
          4 December 20258,04940.2290323,803.46TQEX
          4 December 2025174,64540.41937,059,036.12XETA
          5 December 202520,00040.2031804,061.11AQEU
          5 December 2025100,00040.35664,035,664.65CEUX
          5 December 202510,00040.2085402,084.50TQEX
          5 December 2025174,00040.33277,017,888.10XETA

          A total of 9,871,015 shares have been acquired within the framework of this share buyback.

          The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

          Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.

          08.12.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

          Language:English
          Company:Fresenius Medical Care AG
          Else-Kröner-Straße 1
          61352 Bad Homburg
          Germany
          Internet:www.freseniusmedicalcare.com
           
          End of NewsEQS News Service

          2241958 08.12.2025 CET/CEST

          Disclaimer
          Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Fresenius Medical Care AG : Release of a capital market information

          EQS
          Fresenius Medical Care
          +3.04%

          Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Fresenius Medical Care AG : Release of a capital market information

          24.11.2025 / 17:20 CET/CEST

          Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.

          The issuer is solely responsible for the content of this announcement.

          Fresenius Medical Care AG: Share buyback

          Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Share buyback – Interim Report

          In the period from November 17, 2025 to November 21, 2025 (each inclusive), 1,300,000 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

          Shares were bought back as follows:

          DateAcquired shares (number)Weighted average price (in EUR)Transaction volume (in EUR)Trading venue
          17 November 202510,00040.2658402,657.75AQEU
          17 November 202570,00040.26142,818,300.46CEUX
          17 November 202510,00040.2656402,655.68TQEX
          17 November 2025160,00040.27526,444,031.22XETA
          18 November 202510,00039.5123395,123.30AQEU
          18 November 202580,00039.50183,160,140.81CEUX
          18 November 202510,00039.5062395,062.03TQEX
          18 November 2025150,00039.51085,926,614.42XETA
          19 November 202510,00039.7827397,827.14AQEU
          19 November 202580,00039.78673,182,932.84CEUX
          19 November 202510,00039.7840397,840.31TQEX
          19 November 2025150,00039.78565,967,846.03XETA
          20 November 202510,00039.7568397,568.29AQEU
          20 November 202580,00039.75683,180,546.55CEUX
          20 November 202510,00039.7687397,687.49TQEX
          20 November 2025150,00039.75735,963,601.02XETA
          21 November 20259,76939.9362390,137.04AQEU
          21 November 2025110,00039.94144,393,551.00CEUX
          21 November 20259,75839.9356389,691.50TQEX
          21 November 2025170,47339.93886,808,492.95XETA

          A total of 8,007,783 shares have been acquired within the framework of this share buyback.

          The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

          Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.

          24.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

          View original content: EQS News

          Language:English
          Company:Fresenius Medical Care AG
          Else-Kröner-Straße 1
          61352 Bad Homburg
          Germany
          Internet:www.freseniusmedicalcare.com
           
          End of NewsEQS News Service

          2235192 24.11.2025 CET/CEST

          Disclaimer
          Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Nyse Order Imbalance 27722.0 Shares On Sell Side

          Reuters
          Fresenius Medical Care
          +3.04%
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          BofA survey shows strongest European growth optimism since 2021

          Investing.com
          Tesla
          +1.41%
          NVIDIA
          -0.64%
          Amazon
          +1.69%
          Alphabet-A
          +0.99%
          Advanced Micro Devices
          -0.09%

          Investing.com -- European fund managers are the most upbeat on the continent’s growth outlook in more than four years, with optimism anchored in expectations of German fiscal support and a resilient global backdrop, according to Bank of America’s latest Fund Manager Survey (FMS).

          A net 77% of respondents expect stronger European growth over the next twelve months, up sharply from 57% a month earlier and the highest reading since mid-2021. 

          The surge in optimism comes as investors reassess regional catalysts. Confidence in Germany’s policy stance has strengthened, with 73% citing fiscal stimulus as the key driver of faster growth.

          Meanwhile, European Central Bank (ECB) easing has fallen out of the list of major supports, replaced by expectations that global monetary conditions will turn more favourable.

          A net 3% of global respondents now expect the world economy to strengthen, the first positive reading this year, and the share anticipating a “no-landing” scenario has climbed to 37%, the highest since January.

          “Soft landing remains the majority view on global growth, but the no-landing camp continues to grow,” BofA strategists led by Andreas Bruckner said.

          In terms of potential risks, strategists note that “investors are worried the weakening in the U.S. labour market,” which nearly two-thirds see as the biggest downside risk to global growth, though “not enough to demand action.”

          “Higher-for-longer environment [is] still considered to be the dominant scenario for markets by 42% of respondents, ahead of stagflation at 27% and goldilocks at 19%, up from 7% last month,” the note highlighted.

          The perceived threat from an AI-driven market bubble has also risen, with 45% calling it the top tail risk.

          Still, expectations for core inflation have eased, and a net 27% see lower European inflation ahead, a marked increase from a net 0% last month.

          European equity views have turned even more buoyant. A net 77% expect near-term upside and a record net 92% see gains over the next year. Earnings upgrades are believed to be the primary driver, cited by 77% of investors, and fears of missing a rally are rising.

          The share of respondents concerned about cutting equity exposure too much has climbed to 39%.

          On the positioning front, trends show a tilt back toward cyclicals. A net 31% expect cyclical stocks to outperform defensives, up from 18% previously, although enthusiasm does not extend to small caps, where expectations have swung to neutral.

          Banks remain the biggest consensus overweight, followed by Utilities and Healthcare, while Retail, Media and Food and Beverages are the most under-owned.

          Regionally, Germany remains the preferred equity market, ahead of Spain and Italy. France is the least favoured.

          Cash levels among European investors have risen to 3.8%, while U.S. dollar bearishness has moderated on a global basis.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          BofA’s Hartnett: Positioning and low cash risks for stocks without a December cut

          Investing.com
          Tesla
          +1.41%
          NVIDIA
          -0.64%
          Amazon
          +1.69%
          Alphabet-A
          +0.99%
          Advanced Micro Devices
          -0.09%

          Investing.com -- Positioning has become a growing source of fragility for equities, Bank of America’s November fund manager survey (FMS) shows, with strategists warning that stretched risk-taking leaves stocks exposed if the Federal Reserve does not deliver a rate cut in December.

          Cash levels have fallen to 3.7%, a threshold BofA labels a “sell signal,” and equity allocations have climbed to their highest point since February. Investors are now “most overweight (OW) stocks since February 2025,” BofA highlighted.

          The bank’s strategists, led by Michael Hartnett, stress that FMS positioning is now “a headwind not tailwind for risk assets,” warning that frothy sentiment could “correct further without Fed Dec rate cut.”

          Investors entered November more bullish on the macro backdrop and increasingly confident in a soft landing. A net 3% now expect stronger global growth, the first positive reading of the year, while 53% expect a soft landing and only 6% foresee a hard landing.

          Productivity optimism around artificial intelligence continues to build, with 53% saying AI is already lifting productivity, even as concerns rise about the scale of corporate investment.

          For the first time since 2005, a net 20% of respondents say companies are “overinvesting.”

          “This jump is driven by concerns over the magnitude & financing of the AI capex boom,” strategists noted.

          Crowding, meanwhile, remains elevated. “Long Magnificent 7” reclaimed the title of most crowded trade at 54%, while “AI bubble” was again the top tail risk at 45%. A record 63% of investors believe global equities are overvalued, and more than half say AI stocks are already in bubble territory.

          Private credit remains the most feared source of a systemic credit event, cited by 59% of respondents.

          In terms of asset allocation, investors added to Healthcare, Staples, bonds and Banks in November, while cutting Consumer Discretionary exposure by the most on record. They remain most overweight Healthcare, emerging market (EM) equities and Banks, and most underweight U.K. equities, Energy and Consumer Discretionary.

          Commodities positioning rose to the highest level since September 2022, while cash remains deeply out of favor.

          Forward-looking expectations also leaned constructive. Respondents see international equities and U.S. stocks as the best-performing assets in 2026, and expect MSCI Emerging Markets to lead major indices.

          On currencies, the Japanese yen and gold are viewed as the likely outperformers. 

          The most bullish potential development for next year is “widespread AI productivity gains,” while the most bearish is “inflation & Fed rate hikes.”

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Fresenius Medical Care AG : Release of a capital market information

          EQS
          Fresenius Medical Care
          +3.04%

          Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Fresenius Medical Care AG : Release of a capital market information

          17.11.2025 / 13:54 CET/CEST

          Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.

          The issuer is solely responsible for the content of this announcement.

          Fresenius Medical Care AG: Share buyback

           Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Share buyback – Interim Report

          In the period from November 10, 2025 to November 14, 2025 (each inclusive), 1,250,000 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

          Shares were bought back as follows:

          DateAcquired shares (number)Weighted average price (in EUR)Transaction volume (in EUR)Trading venue
          10 November 202510,00041.4477414,477.47AQEU
          10 November 202580,00041.44643,315,715.42CEUX
          10 November 20255,00041.4430207,214.83TQEX
          10 November 2025155,00041.43536,422,466.61XETA
          11 November 202510,00041.0560410,559.65AQEU
          11 November 202585,00041.05473,489,645.82CEUX
          11 November 20255,00041.0577205,288.66TQEX
          11 November 2025150,00041.05816,158,717.10XETA
          12 November 20256,00041.5325249,195.29AQEU
          12 November 202580,00041.53183,322,544.85CEUX
          12 November 20254,00041.5310166,124.08TQEX
          12 November 2025160,00041.53336,645,330.10XETA
          13 November 20256,00041.1542246,925.31AQEU
          13 November 202575,00041.15883,086,911.61CEUX
          13 November 20254,00041.1542164,616.66TQEX
          13 November 2025165,00041.16716,792,564.91XETA
          14 November 20256,00040.3698242,218.53AQEU
          14 November 202580,00040.37313,229,844.31CEUX
          14 November 20254,00040.3667161,466.71TQEX
          14 November 2025160,00040.37446,459,904.59XETA

          A total of 6,707,783 shares have been acquired within the framework of this share buyback.

          The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

          Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.

          17.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

          View original content: EQS News

          Language:English
          Company:Fresenius Medical Care AG
          Else-Kröner-Straße 1
          61352 Bad Homburg
          Germany
          Internet:www.freseniusmedicalcare.com
           
          End of NewsEQS News Service

          2231062 17.11.2025 CET/CEST

          Disclaimer
          Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Fresenius Medical Care AG : Release of a capital market information

          EQS
          Fresenius Medical Care
          +3.04%

          Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Fresenius Medical Care AG : Release of a capital market information

          10.11.2025 / 16:44 CET/CEST

          Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.

          The issuer is solely responsible for the content of this announcement.

          Fresenius Medical Care AG: Share buyback

          Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

          Share buyback – Interim Report

          In the period from November 3, 2025 to November 7, 2025 (each inclusive), 1,105,000 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

          Shares were bought back as follows:

          DateAcquired shares (number)Weighted average price (in EUR)Transaction volume (in EUR)Trading venue
          3 November 2025135,00046.11296,225,240.36XETA
          4 November 202512,00042.1359505,630.51AQEU
          4 November 202569,00042.13312,907,186.46CEUX
          4 November 20259,00042.1287379,158.63TQEX
          4 November 2025130,00042.62825,541,667.42XETA
          5 November 202510,00041.6334416,334.03AQEU
          5 November 202581,00041.60953,370,370.88CEUX
          5 November 202510,00041.6120416,120.30TQEX
          5 November 2025149,00041.59976,198,355.03XETA
          6 November 20256,00042.3751254,250.71AQEU
          6 November 202585,00042.37143,601,571.67CEUX
          6 November 20255,00042.3863211,931.39TQEX
          6 November 2025154,00042.36886,524,787.76XETA
          7 November 202515,00041.6781625,171.41AQEU
          7 November 202575,00041.67653,125,736.55CEUX
          7 November 202510,00041.6743416,742.52TQEX
          7 November 2025150,00041.68446,252,665.74XETA

          A total of 5,457,783 shares have been acquired within the framework of this share buyback.

          The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

          Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.

          10.11.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

          View original content: EQS News

          Language:English
          Company:Fresenius Medical Care AG
          Else-Kröner-Straße 1
          61352 Bad Homburg
          Germany
          Internet:www.freseniusmedicalcare.com
           
          End of NewsEQS News Service

          2227156 10.11.2025 CET/CEST

          Disclaimer
          Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2025 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Business

          White Label

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          FastBull Membership

          Not yet

          Purchase

          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com